-
Je něco špatně v tomto záznamu ?
The zebrafish model of tuberculosis - no lungs needed
G. Bouz, N. Al Hasawi,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- antituberkulotika farmakologie MeSH
- dánio pruhované * mikrobiologie MeSH
- lidé MeSH
- modely nemocí na zvířatech * MeSH
- Mycobacterium marinum účinky léků fyziologie MeSH
- Mycobacterium tuberculosis účinky léků fyziologie MeSH
- tuberkulóza farmakoterapie mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Tuberculosis is still a global health burden. It is caused by Mycobacterium tuberculosis which afflicts around one third of the world's population and costs around 1.3 million people their lives every year. Bacillus Calmette-Guerin vaccine is inefficient to prevent overt infection. Additionally, the lengthy inconvenient course of treatment, along with the raising issue of antimicrobial resistance, result in incomplete eradication of this infectious disease. The lack of proper animal models that replicate the latent and active courses of human tuberculosis infection remains one of the main reasons behind the poor advancement in tuberculosis research. Danio rerio, commonly known as zebrafish, is catching more attention as an animal model in tuberculosis research field. This shift is based on the histological and pathological similarities between Mycobacterium marinum infection in zebrafish and Mycobacterium tuberculosis infection in humans. Being small, cheap, transparent, and easy to handle have added further advantages to the use of zebrafish model. Besides better understanding of the pathogenesis of tuberculosis, Mycobacterium marinum infected zebrafish model is useful for evaluating novel vaccines against human tuberculosis, high throughput small molecule screening, repurposing established drugs with possible antitubercular activity, and assessing novel antituberculars for hepatotoxicity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027887
- 003
- CZ-PrNML
- 005
- 20190820085911.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/1040841X.2018.1523132 $2 doi
- 035 __
- $a (PubMed)30663918
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bouz, Ghada $u a Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove , Charles University , Hradec Kralove , Czech Republic.
- 245 14
- $a The zebrafish model of tuberculosis - no lungs needed / $c G. Bouz, N. Al Hasawi,
- 520 9_
- $a Tuberculosis is still a global health burden. It is caused by Mycobacterium tuberculosis which afflicts around one third of the world's population and costs around 1.3 million people their lives every year. Bacillus Calmette-Guerin vaccine is inefficient to prevent overt infection. Additionally, the lengthy inconvenient course of treatment, along with the raising issue of antimicrobial resistance, result in incomplete eradication of this infectious disease. The lack of proper animal models that replicate the latent and active courses of human tuberculosis infection remains one of the main reasons behind the poor advancement in tuberculosis research. Danio rerio, commonly known as zebrafish, is catching more attention as an animal model in tuberculosis research field. This shift is based on the histological and pathological similarities between Mycobacterium marinum infection in zebrafish and Mycobacterium tuberculosis infection in humans. Being small, cheap, transparent, and easy to handle have added further advantages to the use of zebrafish model. Besides better understanding of the pathogenesis of tuberculosis, Mycobacterium marinum infected zebrafish model is useful for evaluating novel vaccines against human tuberculosis, high throughput small molecule screening, repurposing established drugs with possible antitubercular activity, and assessing novel antituberculars for hepatotoxicity.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antituberkulotika $x farmakologie $7 D000995
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Mycobacterium marinum $x účinky léků $x fyziologie $7 D019910
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x fyziologie $7 D009169
- 650 _2
- $a tuberkulóza $x farmakoterapie $x mikrobiologie $7 D014376
- 650 12
- $a dánio pruhované $x mikrobiologie $7 D015027
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Al Hasawi, Nada $u b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Kuwait University , Kuwait , State of Kuwait.
- 773 0_
- $w MED00007171 $t Critical reviews in microbiology $x 1549-7828 $g Roč. 44, č. 6 (2018), s. 779-792
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30663918 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190820090146 $b ABA008
- 999 __
- $a ok $b bmc $g 1433036 $s 1066347
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 44 $c 6 $d 779-792 $e 20190121 $i 1549-7828 $m Critical reviews in microbiology $n Crit Rev Microbiol $x MED00007171
- LZP __
- $a Pubmed-20190813